Vitiligo Treatment Market 2022 Analysis May Set New Growth Story, Forecast to 2028
The global vitiligo treatment market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). The increasing disease prevalence for vitiligo across the globe is one of the prime factors affecting and driving the market for vitiligo treatment. As per the information provided by VR Foundation, Inc., in 2020 the total number of people suffering from vitiligo is estimated nearly 65-95 million people across the globe. Generally, vitiligo is related to autoimmune illnesses, also has a negative effect on hearing and eyesight, and is not related to any boundaries of race, ethnicity, or gender. However, various treatments, including topical creams and light therapy, can support some patients as well.
To Request a Sample of our Report on Vitiligo Treatment
Market: https://www.omrglobal.com/request-sample/vitiligo-treatment-market
Moreover, to gain on the opportunity key players operating in the global
vitiligo treatment market had been adopting strategies such as new launches to
achieve major market share. For instance, in December 2021, Incyte Corp. had
set forth that the U.S. Food and Drug Administration (FDA) had accepted for
priority review for the supplemental New Drug Application (sNDA) that is
ruxolitinib cream which is considered as a topical JAK inhibitor, for the
purpose of providing effective treatment in adolescents and adults with
vitiligo.
Market Coverage
·
The market number available for – 2021-2028
·
Base year- 2021
·
Forecast period- 2022-2028
Segment Covered-
·
By Product
·
By Diagnosis
·
By Treatment
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- AVITA Medical, Incyte Corp., TWi Biotechnology,
Dermavant Sciences, Inc., and Clinuvel Pharmaceuticals Ltd.
(Get 15% Discount on Buying this Report)
A
full Report of Vitiligo Treatment Market is Available @ https://www.omrglobal.com/industry-reports/vitiligo-treatment-market
Global Vitiligo Treatment Market Report Segment
By Type
·
Non-Segmental Vitiligo
·
Segmental Vitiligo
By Treatment
·
Therapy
·
Surgery
·
Medication
By End-User
·
Hospitals
·
Aesthetic Clinics
Global Vitiligo Treatment Market Report Segment By Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
Arcutis Biotherapeutics
·
AVITA Medical
·
CLINUVEL PHARMACEUTICALS LTD.
·
Bioniz Therapeutics
·
Dr. Reddy’s Laboratories Ltd.
·
Dermavant Sciences, Inc.
·
Edesa Biotech, Inc.
·
Eli Lilly and Co.
·
Incyte Corp.
·
TWi Biotechnology
·
Temprian Therapeutics Inc.
·
STRATA Skin Sciences
·
Pfizer Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment